Lb Pharmaceuticals Inc (LBRX)

Finanzdaten der Lb Pharmaceuticals Inc-Aktie (LBRX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-07-01
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	143.92%53.92	22.10	13.87	5.25	-
Research and Development	201.44%44.15	14.65	8.48	2.42	-
Nonoperating Income/Loss	24.20%2.31	3.05	2.40	1.69	-
Income/Loss From Continuing Operations Before Tax	170.83%-51.60	-19.05	-11.47	-3.56	-4.87
Income Tax Expense/Benefit	-	-	0.00	-	-
	170.83%-51.60	-19.05	-11.47	-3.56	-4.87
Attributable To Parent	170.83%-51.60	-19.05	-11.47	-3.56	-4.87
Available To Common Stockholders, Basic	170.83%-51.60	-19.05	13.71	-3.56	-4.87
Basic Average Shares	6.71%30.14	28.24	-	5.81	-
Diluted Average Shares	6.71%30.14	28.24	-	5.81	-
Basic Earnings Per Share	155.22%-1.71	-0.67	-	-0.61	-
Diluted Earnings Per Share	155.22%-1.71	-0.67	-	-0.61	-